[go: up one dir, main page]

NO991761L - Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse - Google Patents

Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse

Info

Publication number
NO991761L
NO991761L NO991761A NO991761A NO991761L NO 991761 L NO991761 L NO 991761L NO 991761 A NO991761 A NO 991761A NO 991761 A NO991761 A NO 991761A NO 991761 L NO991761 L NO 991761L
Authority
NO
Norway
Prior art keywords
preparation
acid derivatives
cotocarboxylic
new piperidine
piperidine
Prior art date
Application number
NO991761A
Other languages
English (en)
Norwegian (no)
Other versions
NO991761D0 (no
Inventor
Wilfried Lubisch
Ller Achim M
J Rgen Delzer
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO991761D0 publication Critical patent/NO991761D0/no
Publication of NO991761L publication Critical patent/NO991761L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO991761A 1996-10-15 1999-04-14 Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse NO991761L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19642591A DE19642591A1 (de) 1996-10-15 1996-10-15 Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung
PCT/EP1997/005202 WO1998016512A1 (de) 1996-10-15 1997-09-23 Neue piperidin-ketocarbonsäure-derivate, deren herstellung und anwendung

Publications (2)

Publication Number Publication Date
NO991761D0 NO991761D0 (no) 1999-04-14
NO991761L true NO991761L (no) 1999-04-14

Family

ID=7808858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991761A NO991761L (no) 1996-10-15 1999-04-14 Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse

Country Status (24)

Country Link
US (1) US6380220B1 (tr)
EP (1) EP0934273A1 (tr)
JP (1) JP2001501955A (tr)
KR (1) KR20000049130A (tr)
CN (1) CN1239950A (tr)
AR (1) AR009379A1 (tr)
AU (1) AU736754B2 (tr)
BG (1) BG103338A (tr)
BR (1) BR9711908A (tr)
CA (1) CA2268917A1 (tr)
CO (1) CO4930264A1 (tr)
CZ (1) CZ126899A3 (tr)
DE (1) DE19642591A1 (tr)
HR (1) HRP970549A2 (tr)
HU (1) HUP9904104A3 (tr)
IL (1) IL129089A0 (tr)
NO (1) NO991761L (tr)
NZ (1) NZ334979A (tr)
PL (1) PL332720A1 (tr)
RU (1) RU2189974C2 (tr)
SK (1) SK38599A3 (tr)
TR (1) TR199900819T2 (tr)
WO (1) WO1998016512A1 (tr)
ZA (1) ZA979175B (tr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3819099A (en) 1998-04-20 1999-11-08 Basf Aktiengesellschaft Heterocyclically substituted amides used as calpain inhibitors
JP2002512240A (ja) * 1998-04-20 2002-04-23 ビーエーエスエフ アクチェンゲゼルシャフト 複素環式置換基を有する新規アミド、その製造方法およびその使用
DE19817459A1 (de) 1998-04-20 1999-10-21 Basf Ag Neue heterozyklische substituierte Amide, Herstellung und Anwendung
TR200003068T2 (tr) 1998-04-20 2001-03-21 Basf Aktiengesellschaft Yeni amidler, üretimi ve kullanımı
US6117870A (en) * 1998-11-12 2000-09-12 Fujirebio Kabushiki Kaisha Cyclic amide derivatives
WO2001014331A2 (en) * 1999-08-24 2001-03-01 Regents Of The University Of California Non-quinoline inhibitors of malaria parasites
WO2001023376A1 (en) 1999-09-29 2001-04-05 Ortho-Mcneil Pharmaceutical, Inc. Isonipecotamides for the treatment of integrin-mediated disorders
CA2414960C (en) 2000-06-30 2012-04-10 Seikagaku Corporation Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing .alpha.keto amide compound using them
DE10114762A1 (de) * 2001-03-26 2002-10-02 Knoll Gmbh Verwendung von Cysteinprotease-Inhibitoren
WO2002081467A1 (en) 2001-04-09 2002-10-17 Ortho-Mcneil Pharmaceutical, Inc. Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
JP4617449B2 (ja) 2002-07-11 2011-01-26 ヴィキュロン ファーマシューティカルズ インコーポレイテッド 抗菌活性を有するn−ヒドロキシアミド誘導体
WO2005019177A1 (en) * 2003-08-14 2005-03-03 Icos Corporation Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
KR20070008517A (ko) * 2003-10-24 2007-01-17 아벤티스 파마슈티칼스 인크. 카텝신 저해물질로서 신규한 케토-옥사디아졸 유도체
JP5295976B2 (ja) 2006-12-29 2013-09-18 アボット ゲーエムベーハー ウント カンパニー カーゲー カルボキサミド化合物およびカルパイン阻害剤としてのこれらの使用
TWI453019B (zh) * 2007-12-28 2014-09-21 Abbvie Deutschland 甲醯胺化合物
TWI519530B (zh) 2009-02-20 2016-02-01 艾伯維德國有限及兩合公司 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
US8236798B2 (en) 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
US9051304B2 (en) * 2009-12-22 2015-06-09 AbbVie Deutschland GmbH & Co. KG Carboxamide compounds and their use as calpain inhibitors V
US8598211B2 (en) 2009-12-22 2013-12-03 Abbvie Inc. Carboxamide compounds and their use as calpain inhibitors IV
US9062027B2 (en) 2010-12-09 2015-06-23 AbbVie Deutschland GmbH & Co. KG Carboxamide compounds and their use as calpain inhibitors V
JP2015512427A (ja) 2012-04-03 2015-04-27 アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー カルボキサミド化合物およびそれのカルパイン阻害薬vとしての使用
WO2017156071A1 (en) 2016-03-09 2017-09-14 Blade Therapeutics, Inc. Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
WO2018009417A1 (en) 2016-07-05 2018-01-11 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
WO2018064119A1 (en) 2016-09-28 2018-04-05 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
JP7269875B2 (ja) 2017-06-01 2023-05-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾロキノリン誘導体を含有するレビー小体病治療剤
SG11201909359YA (en) 2017-06-01 2019-11-28 Eisai R&D Man Co Ltd Pharmaceutical composition comprising pde9 inhibitor
SG11202008750XA (en) * 2018-03-28 2020-10-29 Blade Therapeutics Inc Calpain modulators and therapeutic uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904298D0 (sv) * 1989-12-21 1989-12-21 Astra Ab New compounds
CA2098702A1 (en) 1990-12-28 1992-06-29 James C. Powers Peptide ketoamides, ketoacids, and ketoesters
CA2098609A1 (en) * 1990-12-28 1992-06-29 Raymond T. Bartus Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
CA2071621C (en) * 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
JPH09500087A (ja) 1992-06-24 1997-01-07 コーテックス ファーマシューティカルズ インコーポレイテッド カルパイン活性の増大に関連した健康障害の抑制及び処置におけるカルパイン阻害剤の使用法
US5541290A (en) * 1993-06-24 1996-07-30 Harbeson; Scott L. Optically pure calpain inhibitor compounds

Also Published As

Publication number Publication date
NZ334979A (en) 2001-02-23
CZ126899A3 (cs) 1999-07-14
CA2268917A1 (en) 1998-04-23
NO991761D0 (no) 1999-04-14
ZA979175B (en) 1999-04-14
CN1239950A (zh) 1999-12-29
IL129089A0 (en) 2000-02-17
BR9711908A (pt) 1999-08-24
TR199900819T2 (tr) 1999-06-21
CO4930264A1 (es) 2000-06-27
AU736754B2 (en) 2001-08-02
KR20000049130A (ko) 2000-07-25
US6380220B1 (en) 2002-04-30
DE19642591A1 (de) 1998-04-16
WO1998016512A1 (de) 1998-04-23
BG103338A (bg) 2000-01-31
HUP9904104A2 (hu) 2000-05-28
HRP970549A2 (en) 1998-08-31
EP0934273A1 (de) 1999-08-11
PL332720A1 (en) 1999-10-11
AU4777097A (en) 1998-05-11
RU2189974C2 (ru) 2002-09-27
JP2001501955A (ja) 2001-02-13
HUP9904104A3 (en) 2001-01-29
SK38599A3 (en) 2000-04-10
AR009379A1 (es) 2000-04-12

Similar Documents

Publication Publication Date Title
NO991761L (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
NO992821L (no) Ketobenzamider som calpain-inhibitorer
NO20006282L (no) Nye cyklosporiner
NO20012158L (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO974236L (no) Disubstituerte 1,4-piperidinestere og amider som har 5-HT4antagonistisk aktivitet
NO20035210L (no) 2-anilino-pyrimidinderivater som cyklinavhengige kinaseinhibitorer
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
NO20050828L (no) lndol-3-svovelderivater
NO20000841L (no) N-Aroylfenylalanin-derivater
GEP20053470B (en) N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
NO992400L (no) Nye substituerte pyrazolderivater
NO20002958L (no) Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
DE60045508D1 (de) Dalda-analoge und ihre verwendung
NO20002702L (no) Tienopyrimidiner
NO20050087L (no) N-benzoylureido-kanelsyrederivater, fremgangsmate for fremstilling og anvendelse av disse
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
NO20052487L (no) 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.
NO20052182L (no) Nye forbindelser
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20001934L (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
TR199700206A2 (tr) Floralkil- ve floralkoksi ikame edilmis heterosiklik bradikinin-antagonistleri, bunlarin imal edilmesine mahsus usul ve bunlarin kullanilmalari.
NO20023001L (no) Substituerte piperazinderivater som MTP inhibitorer
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application